Rising Surgical Procedures Propelling Tissue Sectioning Market Growth Driving Market Acceleration in the Tissue Sectioning Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Tissue Sectioning Market Size By 2025?
The market size of tissue sectioning has experienced quick expansion in the last few years. It is projected to increase from $0.76 billion in 2024 to $0.83 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%. The historical growth can be credited to a surge in chronic illnesses, an aging population, escalated investments in life science studies, growth in biotechnology and pharmaceutical sectors, governmental support for research, higher demand for companion diagnostics, heightened awareness for early disease detection, and expansion in regenerative medicine.

How Big Is the Tissue Sectioning Market Size Expected to Grow by 2029?
The market size for tissue sectioning is predicted to witness robust growth in the coming years, expanding to $1.21 billion by 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth throughout this forecast period is likely due to an increasing demand for personalized medicine, expansion in biobanks, significant investments in R&D, increased spending in healthcare, heightened awareness regarding early diagnosis of diseases, the advent of digital pathology, growing need for biomarker discovery, burgeoning biopharmaceutical sector, and rising demand for point of care testing. The future period outlines key trends like ongoing technological advancements in automation, the amalgamation of AI and machine learning, integration of digital pathology, adoption of 3D tissue sectioning methods, the evolution of high throughput solutions, widening of research applications, the emergence of new cutting techniques, advancements in imaging modalities, and adoption of cryosectioning techniques.

View the full report here:
https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report

Which Key Market Drivers Powering Tissue Sectioning Market Expansion and Growth?
The tissue sectioning market is poised for growth, propelled by the increasing number of surgical procedures. These medical procedures, which involve the use of instruments to diagnose, treat, or mend the body, have seen a surge due to advancements in medical technology, demographic shifts, and changes in healthcare practices. Tissue sectioning is a crucial component in these surgeries as it offers precise, thin pieces of tissue for histological examination, thus facilitating accurate diagnosis, treatment planning, and transplantation. For example, in December 2023, the Australian Institute of Health and Welfare (AIHW), a government agency in Australia focused on public health and welfare, reported that in 2022-23, the number of patients admitted for surgery from public hospital elective surgery waiting lists reached 735,500. This figure represents an 18% increase from 2021-22. Consequently, the ascending trend in surgical procedures fuels the growth of the tissue sectioning market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16555&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Tissue Sectioning Market?
Key corporations in the field of tissue sectioning are spearheading advancements like next-generation spatial gene expression techniques to improve tissue examination and diagnosis. The said technology allows an in-depth charting of gene activity inside tissue sections, revealing key findings regarding the spatial setup of gene expression and tissue formation. For example, 10x Genomics, a biotechnology firm located in the US, rolled out Visium HD in March 2024. This technology belongs to the next phase in spatial gene expression, enabling meticulous mapping of gene expression in intricate anatomical formations. This is specially created to supply high-resolution spatial gene expression data from formalin-fixed, paraffin-embedded (FFPE) tissue sections at the level of single cell. This technology therefore facilitates in-depth characterization of FFPE tissue sections by charting the whole transcriptome spatial gene expression at a single-cell resolution.

What Are the Emerging Segments in the Tissue Sectioning Market?
The tissue sectioning market covered in this report is segmented -

1) By Product: Accessories And Consumables, Instruments, Services
2) By Technology: Automatic, Manual, Semi-Automatic
3) By Application: Diagnosis, Research
4) By End-User: Clinics, Diagnostic Laboratories, Hospitals, Research Centers

Subsegments:
1) By Accessories And Consumables: Microtome Blades, Staining Reagents, Tissue Embedding Media, Mounting Media, Disposable Consumables (Slides, Coverslips)
2) By Instruments: Microtomes (Manual, Semi-Automated, Fully Automated), Cryostats, Tissue Processors, Tissue Embedding Stations, Sectioning Systems
3) By Services: Maintenance And Repair Services, Calibration Services, Installation Services, Training Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16555&type=smp

Who Are the Global Leaders in the Tissue Sectioning Market?
Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Labcorp Drug Development, Agilent Technologies Inc., Leica Biosystems Nussloch GmbH, Abcam Limited, Sakura Finetek USA Inc., Ted Pella Inc., Santa Cruz Biotechnology Inc., Milestone Srl, Diapath S.p.A., Bio-Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., LLS ROWIAK LaserLabSolutions GmbH, SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc.

Which are the Top Profitable Regional Markets for the Tissue Sectioning Industry?
North America was the largest region in the tissue sectioning market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16555

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.